FDA Investigator Melissa J Garcia

Melissa J Garcia has inspections in 17 countries as of 29 Sep 2023. Melissa J Garcia has collaborated with a combinined 7308 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
77
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100008774
Country:
United States of America, United Kingdom of Great Britain and Northern Ireland, Germany, India, Italy, Denmark, Latvia, Switzerland, France, Ireland, Spain, Portugal, Turkey, Lithuania, Jordan, Malta
Co-Investigator(s):
Adam R Cooke, Ademola O Daramola, Adetutu M Gidado, Alice S Tsao, Alicia M Mozzachio, Alison N Stieg, Amir Alavi, Ana P Barido, Anastasia I Onuorah, Angela E Glenn, Anita R Michael, Anna Lazar, Annet R Rajan, Anthony F Lorenzo, Anthony W Lee, Ariel Cruz Figueroa, Arsen Karapetyan, Asamoah Asamoah, Atul J Agrawal, Azza Talaat, Barbara A Gullick, Barbara I Rogolsky, Barbara J Holladay, Barbara Janine Breithaupt, Barbara L Rogolsky, Benjamin J Smith, Bijoy Panicher, Bijoy Panicker, Bo Chi, PhD, Bonita S Chester, Brandy N Lepage, Brian D Nicholson, Brian L Belz, Brian R Yaun, Brian R Yuan, Brittany D Terhar, Brooke K Higgins, Brooke K Secman, Brooke K Seeman, Bruce C Kovak, Burnell M Henry, Candice C Mandera, Candice J Cortes, Carla A Norris, Carla C Tuite, Carol Mrivera Lopez, PhD, Carole L Jones, Carrie L Doupnik, Caryn M Mcnab, Catherine Whiteside, PhD, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Chaltu N Wakijra, Charisse K Green, Charles Kerns, Charles M Kerns, BLT DO, Cheryl A Clausen, Chiang Syin, PhD, Chris A Sack, Christian D Lynch (CDL), Christina K Theodorou, Christine M Smith, Christine M Whitby, CSO, Christopher D Leach, Christopher S Keating, Chryste D Best, Clarice J Ahn, Colleen F Hoyt, Colleen Thomas, PhD, Concepcion Cruz, Jr, Craig D Zagata, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Daniel J Roberts, David A Oluwo, David J Gomes, David K Glasgow, David M Beltran, Deborah J Parris, Debra I Love, Demitria J Xiradakis, Dennis Cantellops Paite, Dennis L Doupnik, Derek S Smith, PhD, Devaugh Edwards, Devaughn Edwards, Deyaa Shaheen, Diane T Bargo, Diane T O'bien, Diane T O'brien, Dianne H Milazzo, Dipesh K Shah, Donald L Lech, Douglas A Campbell, Dr. Abhijit Raha, PhD, Dr. Barbara D Paul, PhD, Dr. Dominick Roselle, Dr. Gang Wang, PhD, Dr. Roslyn F Powers, Dr. Yubing Tang, Edmund F Mrak, Jr, Edward P Potter, Edwin Melendez, Eileen A Liu, Ellen P Madigan, Emest F Bizjak, Ephrem Hunde, PhD, Eric L Dong, BS, Erik W Koester, Erika V Butler, Erin L Mcfiren, Erk W Koester, Ernest P Bizjak, Fabian Chaparro, Fabian Nchaparro Rodriguez, Felix Maldonado, Francis A Guidry, Gale L Glinecki, Geneve M Maxwell, Geneve M Parks, George J Flynn, George Pyramides, Gerald B Seaborn, Jr, Gerald D Bromley, Jr, German Rivera, Gifford Whitehurst, Jr, Guerlain Ulysse, Gwyn G Dickinson, Hector J Colon Torres, Heika R Tait, Helen B Ricalde, Helen Verdel, Holly S Simms, Hongna Wang, Howard Anderson, PhD, Ivis Lnegron Torres, Jacqueline A O'shaughnessy, PhD, Jacqueline Mdiaz Albertini, Jacqueline S Warner, Jai P Singh, James A Liubicich, James C Maclaughlin, James L Dunnie, Jr, James M Mason, James M Simpson, James W Leonette, Janet A Rajan, Jawaid Hamid, Jazmine N Still, Jean Blackston Hill, Jeffrey A Sommers, Jeffrey D Meng, Jennifer L Huntington, Jesse P Hardin, Jessica D Nanini, Jessica Hankins, PhD, Jessica L Pressley, Joanne Heim, Joel D Hustedt, Joey C West, Joey V Quitania, Jogy George, John Dan, John Dietrick, John J Walsh, John J Welsh, PhD, John Kadavil, PhD, John P Mistler, Johnna L Bleem, Jonah S Ufferfilge, Jonah Ufferfilge, Jonathan W Chapman, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Jose Martinez, Jr, Jose R Hernandez, Joseph W Matthews, Julianne C Mccullough, Julie D Bringger, Junho Opak, Junho Pak, Justin A Boyd, Kara D Dobbin, Katelyn Astaub Zamperini, Katherine Szestypalow, Kathleen M Jordan, Kathryn E Ogger, Keith M Reilly, Kellia N Hicks, Kelly L Anderson, Kenneth Gordon, Kenneth H Williams, Kenneth M Gordon, Kenneth Nieves, Kevin A Gonzalez, Kevin D Kallander, Ko U Min, Kristen D Evans, Kristina L Conroy, Kshitij A Patkar, Lakshmi Narasimhan, PhD, Lanaire J Cortes, Larry K Austin, Latorie S Jones, Latoya S Oliver Powell, Laurie B Frazier, Laurissa S Flowers, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Anastasia Mpiliafas Brown, LCDR Debra Emerson, Liatte Kreuger, PharmD, Libia M Lugo, Linda L Ng, Lori A Holmquist, Lori A Holquist, Lori S Lawless, LT Melanie M Mayor, USPHS, Luella J Rossi, Luis A Dasta, Luis Dosta, Lydia Irosas Marty, Lynette P Salisbury, Malgorzata G Norton, Marcellinus D Dordunoo, Marcia D Fields, Marcus A Ray, Margaret M Doherty, Maria Gutierrez Lugo, PhD, Marianela Aponte Cruz, Marion Michaelis, Mark E Parmon, Martin K Yau, PhD, Massoud Motamed, Matthew B Casale, Matthew M Henciak, Matthew R Dionne, Megan A Haggerty, Meghan Murphy, Meisha R Sampson, Meisha Waters, Melissa T Roy, Merideth K Rose, Michael A Charles, Michael A Taylor, Michael E Maselli, Michael F Skelly, PhD, Michael G Truchan, Michael J Vardon, Michael L Casner, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michelle Marsh, Miguel A Martinez, Mihaly S Ligmond, Milva E Melendez, Minh D Phan, Monique Rac Lester, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy F Scheraga, Nancy M Espinal, Nawab A Siddiqui, Nebil A Oumer, Nerizza B Guerin, Ni A Khin, MD, Nicholas A Violand, Nicole E Knowlton, Nicole K Trudel, Norman Fogg, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Parul Patel Sullivan, Patricia A Morrow, Patricia G Leinbach, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Bellamy, Paul L Figarole, Jr, Paula J Bretz, Paula R Katz, Penny H Mccarver, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Quyen T Tran, Rabin N Ghoshal, Rachael O Oyewole, Rachael Oyewole, Rachel C Harrington, Rafael Nevarez Nieves, Ralph A Erickson, Ralph H Vocque, Raymond T Oji, Rebecca E Dombrowski, Rebecca Rodriguez, Regina Gibson Melton, Regina T Brown, Richard H Penta, Richard Ledwidge (nmi), PhD, Robert D Tollefsen, Robert Durkin, Robert J Maffei, Robert J Martin, Robert M Barbosa, Robin Levis, PhD, Rochelle K Kimmel, Ronald G Crawford, Rose M Ashley, Rose Xu, Roseline N Boateng, Rozelle G Smith, Russell J Glapion, Russell K Riley, S Lori Brown, PhD MPH, Saleem A Akhtar, Sam Pepe, Sandra A Hughes, Sangeeta M Khurana, PhD, Santos E Camara, Sarah E Mcmullen, Satheesh Thomas, Sean R Marcsisin, Sena G Dissmeyer, Seneca D Toms, Sharon K Thoma, PharmD, Sherry L Secrist, BLT DO, Shirshendu K Deb, PhD, Shusheen A Alexander, Simone E Pitts, Sixto M Mercado Rios, Sneha Patel, Sneha S Patel, Stephanie L Shapley, Stephen C Eason, Stephen D Brown, Stephen J Koniers, Steven C Madzo, Steven D Kehoe, Steven E Bowen, PhD, Steven J Thurber, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susanna E Ford, Analyst, Susant Hadman, Suzanne M Healy, Suzanne M Muchene, Swati Verma, Tajah L Blackburn, Tamika E Allen, RN, Tamika White, Tamil Arasu, PhD, Tanika E Allen, RN, Tara G Bizjak, Temar Q Williams, Teresa I Navas, Terri L Dodds, Thai D Truong, Thao T Kwan, Theresa M Smedley, Thomas J Arista, Thomas R Withers, Tiffani D Wilson, Tina M Pawlowski, Tonia F Bernard, Tonya R Johnson, Torrance J Slayton, Toyin B Oladimeji, Tracy L Taras, Tricia S Martinez, Uttaniti Limchumroon (Tom), Vani Mathur Richards, Vesna V Stanoyevitch, Vipulchandr N Dholakia, Viviana Matta, Vivin George, Vlada Matusovsky, Walden H Lee, Walter Fava, Walter L Fava, Wanda Y Fields, Wanda Y Honeyblue, William A Warnick, William H Linkroum, William J Leonard, William L Bargo, Xiaohan Cai, PhD, Xiomara Copeland, Yumi J Hiramine, Yvins Dezan, Yvonne C Mcknight, Zachary L Miller, Zhenzhen Liu, PhD, Zhong Li, PhD, Zhongren Wu

Melissa J Garcia's Documents

Publish Date Document Type Title
April, 2002 FDA 483 Biovail Technologies Ltd. - Form 483, 2002-04-10
October, 2000 FDA 483 Response Sicor Societa' Italiana Corticosteroidi s.r.l - Form 483R, 2001-02-20
October, 2003 EIR Xellia Pharmaceuticals ApS - EIR, 2003-12-16
December, 2004 EIR Mylan Pharmaceuticals Inc. - EIR, 2004-12-10
November, 2005 EIR ACS DOBFAR SPA - EIR, 2005-11-07
January, 2007 FDA 483 Cardinal Health 414, LLC - Form 483, 2007-01-05
May, 2002 FDA 483 Amino Chemicals Ltd - Form 483, 2002-05-20
October, 2003 FDA 483 Xellia Pharmaceuticals ApS - Form 483, 2003-10-03
May, 2002 EIR Schema Farmachemical SRL - EIR, 2002-07-09
August, 2002 FDA 483 Response Actavis Mid-Atlantic, LLC. - Form 483R, 2002-10-03
November, 2002 FDA 483 CIPLA LIMITED - Form 483, 2002-11-14
April, 2004 FDA 483 Barr Laboratories, Inc. (div. Of Teva) - Form 483, 2004-04-14
October, 2000 EIR Sicor Societa' Italiana Corticosteroidi s.r.l - EIR, 2000-10-05
August, 2002 FDA 483 Actavis Mid-Atlantic, LLC. - Form 483, 2002-08-02
September, 2006 FDA 483 Boehringer Ingelheim Chemicals, Inc. - Form 483, 2006-09-15
April, 2005 FDA 483 Pharmaceutics International, Inc. - Form 483, 2005-04-22
May, 2002 FDA 483 Response Schema Farmachemical SRL - Form 483R, 2002-07-26
June, 2003 EIR Cangene BioPharma, LLC - EIR, 2003-06-06
November, 2005 FDA 483 ACS DOBFAR SPA - Form 483, 2005-11-07
November, 2002 EIR CIPLA LIMITED - EIR, 2003-01-17
February, 2004 FDA 483 Alpharma USPD - Form 483, 2004-02-23
October, 2003 FDA 483 Response Xellia Pharmaceuticals ApS - Form 483R, 2003-10-23
March, 2006 FDA 483 Cangene BioPharma, LLC - Form 483, 2006-03-31
May, 2002 FDA 483 Response Amino Chemicals Ltd - Form 483R, 2002-07-19
June, 2003 FDA 483 Response Cangene BioPharma, LLC - Form 483R, 2003-06-19
November, 2004 FDA 483 Cangene BioPharma, LLC - Form 483, 2004-11-15
May, 2004 FDA 483 Response Pharmaceutics International, Inc. - Form 483R, 2004-05-20
August, 2005 FDA 483 Exelead, Inc. - Form 483, 2005-08-19
July, 2003 FDA 483 Dr. Valda Sevele/Ainars Judeiks (Center #2) - Form 483, 2003-07-03
August, 2006 FDA 483 Bell-More Labs Inc - Form 483, 2006-08-17
June, 2003 FDA 483 Cangene BioPharma, LLC - Form 483, 2003-06-06
November, 2002 FDA 483 Response USV Private Limited - Form 483R, 2002-11-22
May, 2002 EIR Amino Chemicals Ltd - EIR, 2002-09-04
August, 2005 EIR Exelead, Inc. - EIR, 2005-08-19
April, 2002 EIR Microchem SRL - EIR, 2002-04-30
November, 2004 FDA 483 Response Cangene BioPharma, LLC - Form 483R, 2005-01-13
November, 2002 FDA 483 USV Limited - Form 483, 2002-11-09
November, 2002 EIR USV Private Limited - EIR, 2008-03-21
December, 2004 EIR Mylan Pharmaceuticals Inc. - EIR, 2004-12-10
May, 2002 FDA 483 Schema Farmachemical SRL - Form 483, 2002-05-07
May, 2004 FDA 483 Pharmaceutics International, Inc. - Form 483, 2004-05-24
June, 2003 EIR Mylan Pharmaceuticals Inc. - EIR, 2003-06-17
April, 2002 FDA 483 Response Microchem SRL - Form 483R, 2002-04-30
February, 2006 FDA 483 Actavis Mid-Atlantic, LLC. - Form 483, 2006-02-17
November, 2004 EIR Cangene BioPharma, LLC - EIR, 2004-11-15
November, 2002 FDA 483 Response CIPLA LIMITED - Form 483R, 2002-11-21
September, 2006 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2006-09-29
September, 2004 FDA 483 Trigen Laboratories, Inc. - Form 483, 2004-09-02
November, 2002 FDA 483 Response CIPLA LIMITED - Form 483R, 2002-12-02
November, 2002 EIR CIPLA LIMITED - EIR, 2003-01-17
May, 2004 EIR Pharmaceutics International, Inc. - EIR, 2004-06-29
May, 2002 EIR Wyeth Lederle SRL - EIR, 2002-05-13
July, 2003 EIR Dr. Valda Sevele/Ainars Judeiks (Center #2) - EIR, 2003-07-03
August, 2005 FDA 483 Response Exelead, Inc. - Form 483R, 2005-09-15
April, 2005 EIR Pharmaceutics International, Inc. - EIR, 2005-04-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more